Discouraging Hypotheses Slows Progress

If Einstein had been a biomedical scientist in the last part of the 20th century, he probably would have died without publishing anything and without making any contribution to science. Einstein was an entirely theoretical scientist: He never did an experiment and showed no interest in conducting experiments personally. The journal referees would have said that he had no experience in the field and that his ideas were mere speculations. Could biomedical science be losing Einsteins and near-Eins

Written byDavid Horrobin
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

All recent studies on the history and philosophy of science have emphasized that hypotheses and theories always come before observation and always condition what will be observed. The idea that scientists observe in a theoretical vacuum and only then incorporate their observations into a hypothesis or theory has been utterly discredited. All observations are theory-laden, and what is observed will always depend on the hypothesis held by the observer. Paradoxically, those most in thrall to theory are those who deny its importance: They fail to recognize that their own observations are dependent on the theories they hold.

Take one very simple example of which I have just become aware. In the late 18th and early 19th centuries one theory of brain organization held that the convolutions of the cerebral cortex were expressions of individuality and hence could exhibit no consistent pattern from person to person. Otherwise reliable observers carefully studied ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies